BRETEC.HE Bioretec Oy

Healthcare Health Care Equipment & Supplies Helsinki Exchange
0.0208 EUR
Close of Oct 29, 2026
0.0120 0.9500
Market cap
EUR 27.9M
P/E
-
P/B
1.54x
ROE
-97.1%
Dividend yield
-
Fundamental score
0.9/5

Ratios use the latest price and the fiscal year ending Dec 2025.

Is BRETEC.HE undervalued?

Graham number

The Graham number of Bioretec Oy cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Bioretec Oy fundamental analysis

5 of 21 checks passed

ROE 0/2

Low return on equity (-52.8%), below 10%.

ROA 0/1

Return on assets (-46.3%) is below the industry median (-8.1%).

Profit Consistency 0/2

Not profitable for at least 3 consecutive years.

Earnings Growth 5Y 0/1

Earnings per share did not grow over the past 5 years.

Earnings Acceleration 0/1

Not enough positive earnings history to compare last year's growth with the 5-year average.

Earnings Growth vs Industry 0/1

Last year's EPS growth (-62.6%) is below the industry median (5.4%).

Revenue Growth 1/2

Revenue grew 6.2% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 0/2

Debt to equity cannot be calculated: debt is not reported or equity is negative.

Debt Trend 0/1

Debt to equity has risen over the past 5 years.

Cash Runway 1/2

Cash covers 1.2 years of the current cash burn.

PE vs Market 0/1

PE is negative or not available.

PE vs Industry 0/1

PE is negative or not available.

PBV 1/1

Price to book (1.5x) is below the industry median (1.9x).

Graham Number 0/1

Graham number needs positive earnings and book value.

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 0/2

No dividend paid in the last reported year.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 0/1

No dividend, or no profit to pay it from.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

Bioretec Oy stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Bioretec Oy

Bioretec Oy, a medical device company, develops, manufactures, and markets bioresorbable orthopedic implants for the repair of bone and soft tissue injuries in children and adults worldwide. The company offers Activa IM-Nail, a bioabsorbable option for pediatric forearm intramedullary nailing; ActivaNail, an implant that is be used in upper or lower limbs to ensure successful bone regeneration; ActivaPin, a bioabsorbable implant for upper and lower limb fractures; and Activa…

Full company profile